Godavari Drugs Ltd share price logo

Godavari Drugs Share Price

BSE: 530317

Small Cap

Healthcare Sector

₹102.30

+14.08

(+15.96%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Godavari Drugs Stock Performance

as on January 16, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹88.90
    ₹105.40
    downward going graph

    13.10%

    Downside

    3.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹69.70
    ₹118.95
    downward going graph

    31.87%

    Downside

    16.28%

    Upside

    downward going graph

Godavari Drugs share price movements today

Previous Close
₹88.22
Open
₹88.90
Volume
90.75K
Upper Circuit
₹105.86
Lower Circuit
₹70.58
Day's Low - High
₹88.90 - ₹105.40
52 Week Low - High
₹69.70 - ₹118.95

Godavari Drugs Historical Returns

1 Month Return
+ 36.21 %
3 Month Return
+ 27.57 %
1 Year Return
-3.99 %
3 Year Return
+ 13.34 %
5 Year Return
+ 134.62 %

Godavari Drugs Fundamentals

as on January 16, 2026 at 4:01 pm IST

Market Cap

₹76.86 Cr

Return on Equity (ROE)

10.64

PE Ratio (TTM)

0

Return on capital employed (ROCE)

10.06

Beta (LTM)

0.54

P/B Ratio

1.52

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-8.26

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Godavari Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Godavari Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA76.8626.92%0.004113
Astonea Labs Ltd image
Astonea Labs Ltd
NA168.183.59%0.00597
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA20,660.0021.05%0.001151,716
RPG Life Sciences Ltd image
RPG Life Sciences Ltd
NA3,815.88107.73%0.00183653
Solara Active Pharma Sciences Ltd Partly Paidup image
Solara Active Pharma Sciences Ltd Partly Paidup
NA455.9515.54%0.00NANA
See all

Godavari Drugs Share Price Target

Get share price movements and forecasts by analysts on Godavari Drugs.

Source: S&P Global Market Intelligence

Godavari Drugs Stock’s Investor Sentiment and Interest

Search interest for Godavari Drugs Ltd Stock has increased by 168% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:168% versus previous 30 day period

Godavari Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
37.37
35.42
39.54
43.11
38.64
32.21
26.09
29.55
25.5
23.81
26.65
Other Income
0.39
0.45
-
0.05
0.11
0.77
0.01
0.1
0.11
0.01
0.64
Total Income
37.76
35.87
39.55
43.16
38.75
32.97
26.1
29.65
25.61
23.82
27.28
Expenses
34.69
33.17
36.48
39.65
34.2
28.98
23.18
26.97
22.39
20.91
24.65
Operating Profit
2.68
2.25
3.06
3.46
4.44
3.23
2.91
2.58
3.11
2.9
2
Operating Profit Margin %
7.17%
6.35%
7.74%
8.03%
11.49%
10.03%
11.15%
8.73%
12.2%
12.18%
7.5%
Profit Before Interest, Tax and Depreciation
3.07
2.7
3.07
3.51
4.55
4
2.91
2.68
3.22
2.91
2.63
Interest
1.03
1.11
1.3
1.27
1.23
1.44
1.08
1.11
1.11
1
0.91
Depreciation
0.5
0.47
0.49
0.5
0.53
0.55
0.58
0.64
0.67
0.6
0.6
Profit Before Tax
1.54
1.12
1.28
1.74
2.79
2.01
1.25
0.93
1.44
1.31
1.12
Tax Paid
0.21
0.31
0.42
0.52
0.13
0.38
0.16
0.15
0.55
0.26
0.12
Profit After Tax
1.33
0.81
0.86
1.22
2.66
1.63
1.09
0.77
0.89
1.04
1
Total Net profit including share of profit / Loss from associate company
1.33
0.81
0.86
1.22
2.66
1.63
1.09
0.77
0.89
1.04
1
EPS
1.77
1.08
1.14
1.62
3.53
2.17
1.45
1.02
1.19
1.38
1.33
Actual EPS
1.77
1.08
1.14
1.62
3.53
2.17
1.45
1.02
1.19
1.38
1.33
Adjusted EPS
1.77
1.08
1.14
1.62
3.53
2.17
1.45
1.02
1.19
1.38
1.33
Diluted EPS
1.77
1.08
1.14
1.62
3.53
2.17
1.45
1.02
1.19
1.38
1.33

Godavari Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
75.6
64.45
83.54
95.7
122.67
161.11
159.62
156.71
113.35
Other Income
0.8
0.68
0.24
0.33
0.41
0.28
0.88
0.62
0.98
Total Income
76.4
65.12
83.79
96.03
123.08
161.38
160.51
157.33
114.33
Expenses
70.38
60.41
78.07
89.66
112.84
149.82
149.7
143.5
101.52
Operating Profit
5.22
4.04
5.47
6.04
9.83
11.29
9.92
13.21
11.83
Operating Profit Margin %
6.9%
6.27%
6.55%
6.31%
8.01%
7.01%
6.21%
8.43%
10.44%
Profit Before Interest, Tax and Depreciation
6.02
4.72
5.72
6.36
10.24
11.57
10.81
13.83
12.81
Interest
2.51
2.42
2.89
2.91
3.31
2.85
3.93
4.92
4.73
Depreciation
0.81
0.99
1.09
1.16
1.22
1.7
1.94
1.99
2.45
Profit Before Tax
2.7
1.31
1.74
2.29
5.71
7.02
4.94
6.92
5.63
Tax Paid
0.89
0.48
0.54
0.29
1.58
1.78
1.15
1.37
1.25
Profit After Tax
1.81
0.83
1.21
2
4.13
5.25
3.79
5.55
4.38
Total Net profit including share of profit / Loss from associate company
1.81
0.83
1.21
2
4.13
5.25
3.79
5.55
4.38
EPS
2.4
1.1
1.6
2.66
5.48
6.97
5.03
7.37
5.82
Actual EPS
2.4
1.1
1.6
2.66
5.48
6.97
5.03
7.37
5.82
Adjusted EPS
2.4
1.1
1.6
2.66
5.48
6.97
5.03
7.37
5.82
Diluted EPS
2.4
1.1
1.6
2.66
5.48
6.97
5.03
7.37
5.82

Godavari Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-4.53
5.15
3.82
3.71
6.24
1.33
11.23
13.22
18.41
11.2
Cash Flow from Investing Activities
-2.08
-2.97
-2.94
-2.34
-6.68
-1.25
-4.98
-8.64
-13.22
-19.51
Cash Flow from Financing Activities
7
-1.95
-0.15
-1.46
0.34
0.14
-5.62
-3.77
-5.65
8.07
Net Cash Flow
0.39
0.23
0.73
-0.09
-0.1
0.21
0.64
0.81
-0.46
-0.25

Godavari Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
53.12%
53.16%
53.16%
53.16%
53.16%
53.16%
52.63%
52.63%
52.63%
52.63%
52.61%
DII
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
Public
46.38%
46.34%
46.34%
46.34%
46.34%
46.34%
46.87%
46.87%
46.87%
46.87%
46.89%
Total Outstanding Shares
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
75,30,500
Total Shareholders
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915
7,881
7,828
7,720

Godavari Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Godavari Drugs.

  • Godavari Drugs Ltd Earnings Results

    Godavari Drugs Ltd’s net profit fell -8.26% since last year same period to ₹1.00Cr in the Q2 2025-2026. On a quarterly growth basis, Godavari Drugs Ltd has generated -3.85% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Godavari Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 46.87% to 46.89% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Godavari Drugs stock has moved up by 19.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.6% return, outperforming this stock by 30.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.4% return, outperforming this stock by 140.1%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 52.63% to 52.61% in Sep 2025 quarter

About Godavari Drugs Ltd

Godavari Drugs (GD) is a drug manufacturing company with the main product being Sulphamethoxazole (SMX). In order to increase their SMX capacity from 540 tons per annum (tpa) to 720 tpa, the company is undertaking backward integration into the manufacture of 450 tpa drug intermediates Sulphamethoxide (SMO) and 750 tpa Diethyl Oxalate (DEO) as well as diversifying into 144 tpa Trimetroprim (TMP). Combining SMX and TMP provides treatment for a broader range of infections. GD also introduced Pyrazyamide (180 tpa) in 2000 and is now planning to increase its capacity, along with a new intermediate Cislactum for the production of anti anginal drug Diltiazem. All actions to increase value-addition are set to give GD profitable export demand.

Revenue: ₹26.65Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1.00Cr as on September 2025 (Q2 FY26)
Chairperson Name: Ghanshyam Jaju
OrganisationGodavari Drugs Ltd
IndustryPharmaceuticals
CEOGhanshyam Jaju
E-voting on sharesClick here to vote

FAQs

What is Godavari Drugs share price today?

Godavari Drugs share price today stands at ₹102.3 as on at the close of the market. Godavari Drugs share today touched a day high of ₹105.4 and a low of ₹88.9.

What is the 52 week high and 52 week low range for Godavari Drugs share?

Godavari Drugs touched a 52 week high of ₹118.95 and a 52 week low of ₹69.7. Godavari Drugs share price today i.e. is closed at ₹102.3, which is -14.00% down from its 52 week high and 46.77% up from its 52 week low.

What is Godavari Drugs's market capitalisation today?

Godavari Drugs market capitalisation is ₹76.86 Cr as on .

How to buy Godavari Drugs shares?

To buy Godavari Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 530317 or Godavari Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Godavari Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Godavari Drugs trading volume today?

Godavari Drugs trading volume is 90.75K as on . This means that 90.75K shares of Godavari Drugs were bought and sold on the stock market during today's trading session.